Results 11 to 20 of about 239,504 (244)

Mixed connective tissue disease, undifferentiated connective tissue disease and overlap syndromes

open access: yesAlʹmanah Kliničeskoj Mediciny, 2019
Systemic lupus erythematosus, systemic sclerosis, inflammatory myopathy and rheumatoid arthritis are systemic connective tissue disorders which are characterized by heterogeneous clinical symptoms and variable course. To date, updated diagnostic criteria
R. T. Alekperov
doaj   +1 more source

Mixed connective tissue disease

open access: yesСовременная ревматология, 2019
Mixed connective tissue disease (MCTD), also known as Sharp's syndrome, is a rare systemic connective tissue disorder that characterized by a combination of some features of systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis ...
R. U. Shayakhmetova, L. P. Ananyeva
doaj   +1 more source

Modulation of Fibrosis in Systemic Sclerosis by Nitric Oxide and Antioxidants

open access: yesCardiology Research and Practice, 2012
Systemic sclerosis (scleroderma: SSc) is a multisystem, connective tissue disease of unknown aetiology characterized by vascular dysfunction, autoimmunity, and enhanced fibroblast activity resulting in fibrosis of the skin, heart, and lungs, and ...
Audrey Dooley   +2 more
doaj   +1 more source

Systemic anaplastic large cell lymphoma presenting as a huge mediastinal mass in a case of hyper IgE syndrome: a case report

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2019
Background Hyper IgE syndrome is a rare heterogeneous immunodeficiency syndrome which is characterized by recurrent episodes of cutaneous and respiratory tract infections and development of cold abscesses.
Atefeh Kheyrollahiyan   +2 more
doaj   +1 more source

Determining the Frequency of Macroamylasemia in Patients with Hyperamylasemia using PEG Precipitation Method [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Introduction: The term acute abdomen refers to severe and sudden abdominal pain requiring urgent reorganisation. One of the factors causing acute abdomen is acute pancreatitis, which needs immediate measurements.
Amir Vahedi   +6 more
doaj   +1 more source

Mixed connective tissue disease and severe renal disease – an apparent misconception?

open access: yesRheumatology, 2022
not required for Letter to Editor Abstract not required for Letter to Editor Abstract not required for Letter to Editor Abstract not required for Letter to Editor Abstract not required for Letter to Editor Abstract not required for Letter to Editor ...
Filipe Oliveira Pinheiro   +3 more
doaj   +1 more source

Nitric Oxide Manipulation: A Therapeutic Target for Peripheral Arterial Disease?

open access: yesCardiology Research and Practice, 2012
Peripheral Arterial Disease (PAD) is a cause of significant morbidity and mortality in the Western world. Risk factor modification and endovascular and surgical revascularisation are the main treatment options at present. However, a significant number of
Gareth Williams   +5 more
doaj   +1 more source

Toll-Like Receptors in Ischaemia and Its Potential Role in the Pathophysiology of Muscle Damage in Critical Limb Ischaemia

open access: yesCardiology Research and Practice, 2012
Toll-like receptors (TLRs) are key receptors of the innate immune system which are expressed on immune and nonimmune cells. They are activated by both pathogen-associated molecular patterns and endogenous ligands.
Hemanshu Patel   +5 more
doaj   +1 more source

Cutaneous mucinosis in mixed connective tissue disease* [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2013
Cutaneous mucinosis is a group of conditions involving an accumulation of mucin or glycosaminoglycan in the skin and its annexes. It is described in some connective tissue diseases but never in association with mixed connective tissue disease.
Maria Helena Sampaio Favarato   +5 more
doaj   +1 more source

Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells

open access: yesFEBS Letters, EarlyView.
Imeglimin, at clinically relevant concentrations, inhibits vesicular ATP accumulation and release from hepatic stellate cells, thereby attenuating purinergic signaling and reducing fibrogenic activation. This mechanism reveals a newly identified antifibrotic action of imeglimin beyond glycemic control.
Seiji Nomura   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy